Clinical risk score can be used to select patients for staging laparoscopy and laparoscopic ultrasound for colorectal liver metastases

World Journal of Surgery

Volumn 34, Issue 9, 2010, Pages 2141-2145

  Shah, A J ^a   Phull, J ^b   Finch Jones, M D ^c  

^a SIR GANGA RAM HOSPITAL   (India)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ARTICLE; COLORECTAL TUMOR; ECHOGRAPHY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LIVER TUMOR; PATHOLOGY; PATIENT SELECTION; RETROSPECTIVE STUDY; RISK ASSESSMENT;

ALGORITHMS; COLORECTAL NEOPLASMS; HUMANS; LAPAROSCOPY; LAPAROTOMY; LIVER NEOPLASMS; PATIENT SELECTION; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 79952108780     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-010-0630-1     Document Type: Article

References (38)

1. Weitz J, Koch M, Debus J et al (2005) Colorectal cancer. Lancet 365(9454):153-165
2. Steele G Jr, Ravikumar TS (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210(2):127-138
3. Geoghegan JG, Scheele J (1999) Treatment of colorectal liver metastases. Br J Surg 86(2):158-169
4. Jatzko G, Wette V, Muller M et al (1991) Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital. Int J Colorectal Dis 6(2):111-114
5. Blumgart LH, Allison DJ (1982) Resection and embolization in the management of secondary hepatic tumors. World J Surg 6(1):32-45
6. Finlay IG, McArdle CS (1986) Occult hepatic metastases in colorectal carcinoma. Br J Surg 73(9):732-735
7. Scheele J, Stang R, Altendorf-Hofmann A, Paul M (1995) Resection of colorectal liver metastases. World J Surg 19(1): 59-71
8. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP (1991) Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110(1):13-29
9. Fong Y, Fortner J, Sun RL et al (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230(3): 309-318 (discussion 318-321)
10. Are C, Gonen M, Zazzali K et al (2007) The impact of margins on outcome after hepatic resection for colorectal metastasis. Ann Surg 246(2):295-300
11. Choti MA, Sitzmann JV, Tiburi MF et al (2002) Trends in longterm survival following liver resection for hepatic colorectal metastases. Ann Surg 235(6):759-766
12. Fernandez FG, Drebin JA, Linehan DC et al (2004) Five-year survival after resection of hepatic metastases from colorectal cancer in patients screened by positron emission tomography with F-18 fluorodeoxyglucose (FDG-PET). Ann Surg 240(3):438-447 (discussion 447-450)
13. Laurent C, Sa Cunha A, Couderc P et al (2003) Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases. Br J Surg 90(9):1131-1136
14. Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241(5):715-722 (discussion 722-724)
15. Shaw IM, Rees M, Welsh FK et al (2006) Repeat hepatic resection for recurrent colorectal liver metastases is associated with favourable long-term survival. Br J Surg 93(4):457-464
16. Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231(4):487-499
17. Andre T, Tournigand C, Mineur L et al (2007) Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study. Ann Oncol 18(1):77-81
18. de Gramont A, Figer A, Seymour M et al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938-2947
19. Giantonio BJ, Catalano PJ, Meropol NJ et al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 25(12):1539-1544
20. Goldberg RM, Sargent DJ, Morton RF et al (2004) A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22(1):23-30
21. Masi G, Allegrini G, Cupini S et al (2004) First-line treatment of metastatic colorectal cancer with irinotecan, oxaliplatin and 5-fluorouracil/leucovorin (FOLFOXIRI): results of a phase II study with a simplified biweekly schedule. Ann Oncol 15(12): 1766-1772
22. Seium Y, Stupp R, Ruhstaller T et al (2005) Oxaliplatin combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Ann Oncol 16(5):762-766
23. Stathopoulos GP, Rigatos SK, Stathopoulos JG et al (2005) Efficacy and tolerability of oxaliplatin plus irinotecan 5-fluouracil and leucovorin regimen in advanced stage colorectal cancer patients pretreated with irinotecan 5-fluouracil and leucovorin. Am J Clin Oncol 28(6):565-569
24. Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. Ann Surg Oncol 8(4):347-353
25. Capussotti L, Muratore A, Mulas MM et al (2006) Neoadjuvant chemotherapy and resection for initially irresectable colorectal liver metastases. Br J Surg 93(8):1001-1006
26. Sjovall A, Jarv V, Blomqvist L et al (2004) The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol 30(8):834-841
27. John TG, Greig JD, Crosbie JL et al (1994) Superior staging of liver tumors with laparoscopy and laparoscopic ultrasound. Ann Surg 220(6):711-719
28. Koea J, Rodgers M, Thompson P et al (2004) Laparoscopy in the management of colorectal cancer metastatic to the liver. ANZ J Surg 74(12):1056-1059
29. Metcalfe MS, Close JS, Iswariah H et al (2003) The value of laparoscopic staging for patients with colorectal metastases. Arch Surg 138(7):770-772
30. Rahusen FD, Cuesta MA, Borgstein PJ et al (1999) Selection of patients for resection of colorectal metastases to the liver using diagnostic laparoscopy and laparoscopic ultrasonography. Ann Surg 230(1):31-37
31. D'Angelica M, Fong Y, Weber S et al (2003) The role of staging laparoscopy in hepatobiliary malignancy: prospective analysis of 401 cases. Ann Surg Oncol 10(2):183-189
32. Jarnagin WR, Fong Y, Ky A et al (1999) Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg 188(1):33-42
33. Mann CD, Neal CP, Metcalfe MS et al (2007) Clinical Risk Score predicts yield of staging laparoscopy in patients with colorectal liver metastases. Br J Surg 94(7):855-859
34. Huebner RH, Park KC, Shepherd JE et al (2000) A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41(7):1177-1189
35. Ward J, Robinson PJ, Guthrie JA et al (2005) Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology 237(1):170-180
36. Ruers TJ, Langenhoff BS, Neeleman N et al (2002) Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20(2):388-395
37. Strasberg SM, Dehdashti F, Siegel BA et al (2001) Survival of patients evaluated by FDG-PET before hepatic resection for metastatic colorectal carcinoma: a prospective database study. Ann Surg 233(3):293-299
38. Jarnagin WR, Conlon K, Bodniewicz J et al (2001) A clinical scoring system predicts the yield of diagnostic laparoscopy in patients with potentially resectable hepatic colorectal metastases. Cancer 91(6):1121-1128